Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07723482
What this trial is testing

ML-016 in Advanced Cancer With Lung and/or Liver Involvement

Who this might be right for
Advanced Solid Tumor With Lung and/or Liver Involvement
BrYet US, Inc. 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT02932280
What this trial is testing

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Who this might be right for
Solid TumorCentral Nervous System TumorLymphoma+1 more
Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)Looking for participantsNCT06063681
What this trial is testing

SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced / Metastatic Solid Tumor
Stingray Therapeutics 25
Early research (Phase 1)Ended earlyNCT01159301
What this trial is testing

Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108
What this trial is testing

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Who this might be right for
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07630974
What this trial is testing

Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 134
Early research (Phase 1)Ended earlyNCT02875223
What this trial is testing

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 75
Early research (Phase 1)Study completedNCT00555724
What this trial is testing

Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Biogen 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06494579
What this trial is testing

Lamivudine for Solid Tumors

Who this might be right for
Relapsed/Refractory Solid Tumors
Thomas Marron 12
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT01295697
What this trial is testing

Study of EZN-2208 Pediatric Patients With Solid Tumors

Who this might be right for
Solid Tumors
Enzon Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06541262
What this trial is testing

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Who this might be right for
NeuroblastomaEwing SarcomaOsteosarcoma+2 more
Milton S. Hershey Medical Center 104
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01349660
What this trial is testing

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
SCRI Development Innovations, LLC 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT05662397
What this trial is testing

HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Who this might be right for
Solid Tumor, AdultRelapsed CancerRefractory Cancer
HotSpot Therapeutics, Inc 77
Early research (Phase 1)Active Not RecruitingNCT05718557
What this trial is testing

Study of PYX-106 in Solid Tumors

Who this might be right for
Solid Tumor
Pyxis Oncology, Inc 47
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Active Not RecruitingNCT04606433
What this trial is testing

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 47
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Next Page